Circulating Angiogenic Cytokines in Pancreatic Cancer
Author Information
Author(s): Rahbari Nuh N, Schmidt Thomas, Falk Christine S, Hinz Ulf, Herber Magdalene, Bork Ulrich, Büchler Markus W, Weitz Jürgen, Koch Moritz
Primary Institution: University of Heidelberg
Hypothesis
The study investigates the expression and prognostic associations of circulating angiogenic cytokines in patients with pancreatic cancer.
Conclusion
Certain circulating angiogenic cytokines correlate with patients' prognosis after resection for pancreatic cancer when considered as a panel.
Supporting Evidence
- High levels of circulating PDGF-AA were associated with poor cancer-specific survival.
- High levels of VEGF, PDGF-BB, and Ang-1 were associated with favorable prognosis.
- Circulating levels of certain angiogenic cytokines were significantly different in pancreatic cancer patients compared to healthy controls.
Takeaway
This study found that some proteins in the blood can help predict how well patients with pancreatic cancer will do after surgery.
Methodology
Serum samples were collected from patients undergoing surgery for pancreatic cancer and analyzed using enzyme-linked immunosorbent assays and multiplex protein arrays.
Limitations
The study excluded patients who received neoadjuvant therapy and those with a history of second malignancies.
Participant Demographics
The study included 74 patients with a median age of 67.1 years, consisting of 50% men and 50% women.
Statistical Information
P-Value
p < 0.0001 for several cytokines
Confidence Interval
95% confidence interval 1.43 - 14.69 for PDGF-AA
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website